CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III, Open, Multicenter Study to Assess the Long-Term Persistence of a Booster Dose of GSK Biologicals' Hib-MenC Compared to a Booster Dose of Infanrix™ Hexa When Given to 14 Month-old Subjects Primed in Study DTPa-HBV-IPV-097 & Boosted in Study Hib-MenC-TT-010 BST: DTPa-HBV-IPV-097

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00322335
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:24.308034+00:00
Published At: 2011-01-14T00:00:00+00:00
Record Updated At: 2016-10-20
Results Posted At: 2011-01-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-10-20"
protocolSection.identificationModule.nctId: "NCT00322335"
protocolSection.identificationModule.officialTitle: "Phase III, Open, Multicenter Study to Assess the Long-Term Persistence of a Booster Dose of GSK Biologicals\u0027 Hib-MenC Compared to a Booster Dose of Infanrix\u2122 Hexa When Given to 14 Month-old Subjects Primed in Study DTPa-HBV-IPV-097 \u0026 Boosted in Study Hib-MenC-TT-010 BST: DTPa-HBV-IPV-097"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-01-14"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.